PAA 2.50% 20.5¢ pharmaust limited

Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-128

  1. 1,267 Posts.
    lightbulb Created with Sketch. 427
    That's it, it seems to simply be a (for the moment) 'they own the product, PAA own the process' thing. It's just a matter of waiting until they no longer own the matter.. Aha-ha.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.